Cargando…
Nebulized Bacteriophage in a Patient With Refractory Mycobacterium abscessus Lung Disease
An elderly man with refractory Mycobacterium abscessus lung disease previously developed anti-phage neutralizing antibodies while receiving intravenous phage therapy. Subsequent phage nebulization resulted in transient weight gain, decreased C-reactive protein, and reduced Mycobacterium burden. Weak...
Autores principales: | Dedrick, Rebekah M, Freeman, Krista G, Nguyen, Jan A, Bahadirli-Talbott, Asli, Cardin, Mitchell E, Cristinziano, Madison, Smith, Bailey E, Jeong, Soowan, Ignatius, Elisa H, Lin, Cheng Ting, Cohen, Keira A, Hatfull, Graham F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251665/ https://www.ncbi.nlm.nih.gov/pubmed/35794944 http://dx.doi.org/10.1093/ofid/ofac194 |
Ejemplares similares
-
The problem of Mycobacterium abscessus complex: multi-drug resistance, bacteriophage susceptibility and potential healthcare transmission
por: Dedrick, Rebekah M., et al.
Publicado: (2023) -
Bacteriophage treatment of disseminated cutaneous Mycobacterium chelonae infection
por: Little, Jessica S., et al.
Publicado: (2022) -
Global phylogenomic analyses of Mycobacterium abscessus provide context for non cystic fibrosis infections and the evolution of antibiotic resistance
por: Bronson, Ryan A., et al.
Publicado: (2021) -
Engineered bacteriophages for treatment of a patient with a disseminated drug resistant Mycobacterium abscessus
por: Dedrick, Rebekah M., et al.
Publicado: (2019) -
Genome Sequence of Mycobacterium abscessus Phage phiT46-1
por: Amarh, Elizabeth D., et al.
Publicado: (2021)